endometriosis
Conditions
Interventions
combination drug is administarated for 3 months
single drug is administarated for 3 months
Sponsors
The University of Tokyo Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1 patients who obtained the diagnosis of endometriosis 1-1 Past history of operation for endometriosis. diagnosed pathologically or surgical findings with the observation at the operation. 1-2 The patient diagnosed endometriosis by an internal exam or ultrasound exam 2 The menstrual cycle is within 25-31days low dose EP is unconcerned. 3 Use at least one dose of painkiller dualing the time of menstrual periods.
Exclusion criteria
Exclusion criteria: 1) have severe asthma or allergy to multiple drugs 2) has diarrhea by uptake of dairy goods 3) have past history of allergy to dairy products 4) cervical cytology worse than class 2 5) have carcinoma 6) severe hepatic or renal damage or have past history of cardiac infarct 7) past history of hepatitis 8) severe anemia 9) appropriate judged by responsible doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain is assessed with VAS. The average score of menstrual pain when combination drug is used is compared with that of menstrual pain when single drug is used | — |
Countries
Japan
Contacts
Public ContactTAKAMURA MASASHI
University of Tokyo Obstetrics and Gynecology
Outcome results
None listed